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Summary 
Urolithiasis is one of the most common urologic diseases in the world. It describes the 
formation of urinary calculi in the urinary system. According to forecasts, urolithiasis has a 
continuing upward trend due to a significant change in the nature and quality of nutrition, 
increase of negative environmental and social factors. Despite the large-scale implementation 
and application of highly effective methods for urolithiasis diagnosis and treatment, the 
incidence of stone formation and recurrence remains high (30-50%). In study was determine the 
effectiveness of usage Canephron®N (dragees) in the complex prophylaxis of recurrent stone 
formation in patients with urolithiasis. 
 
Rezumat 
Eficacitatea preparatului Canefron®N în metafilaxia urolitiazei 
Urolitiaza este cea mai răspîndită patologie urologică în lume. Aceasta patologie este 
descrisă ca formarea calculilor în sistemul urinar. În conformitate cu pronosticul, urolitiaza are o 
continuă tendinţa ascendentă datorită schimbărilor semnificatie în natura şi în calitatea 
alimentelor, acţiunea nefastă a mediului ambiant şi factorilor sociali, metabolici şi infecţioşi. 
Necătînd la aplicarea şi implementarea pe scara largă a metodelor eficace în diagnosticarea şi 
tratamentul urolitiazei, incidenţa formării calculilor şi recurenţa rămâne înaltă (30 – 50 %). În 
studiu este determinată eficacitatea utilizării preparatului Canefron®N în metafilaxia complexă 
la pacienţii cu urolitiază recidivantă. 
 
Introduction 
Urolithiasis is one of the most common urologic diseases in the world. It describes the 
formation of urinary calculi in the urinary system. Currently, urolithiasis ranks first in the 
structure of diseases in the Urology Departments of the Republic of Moldova.  
According to forecasts, urolithiasis has a continuing upward trend due to a significant 
change in the nature and quality of nutrition, increase of negative environmental and social 
factors. The topicality of the urolithiasis problem is conditioned by its frequent diagnosis in 
individuals of more able-bodied period of life (aged 20-60).  
The pathophysiology of urolithiasis is still under debate and seems to be multifactorial 
such as physicochemical and metabolic trigger mechanisms. A main physicochemical trigger is 
supersaturation, e.g. as expressed as the ratio of urinary calcium oxalate or calcium phosphate 
concentration to the solubility, which is the driving force for stone formation. About 80% of 
stones are composed of calcium oxalate with variable amounts of calcium phosphate. Calcium 
oxalate supersaturation is independent of urine pH, but calcium phosphate supersupersaturation 
increases rapidly as urine pH rises from 6 to 7. Other triggers are of metabolic nature, such as 
imbalances between excretions of calcium, oxalate, and water which create supersaturation. 
Despite the large-scale implementation and application of highly effective methods for 
urolithiasis diagnosis and treatment, the incidence of stone formation and recurrence remains 
high (30-50%).  
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A comprehensive, personalized metaphylaxis, with a change in lifestyle, diets, increased 
water consumption, use of phytomedicines increases the effectiveness of the treatment. 
Herbal drugs play a specific role in the conservative treatment of urologic complaints, 
especially for secondary prevention of urinary tract infections and renal inflammation as well as 
for the prevention of renal gravel. In cases of urolithiasis herbal drugs as e.g. Equiseti herba, 
Levistici radix, Urticae herba/folium and Solidaginis herba are used since many centuries. The 
main therapeutic strategy is the increase of urinary flow and the dilution of the urine, resulting in 
a reduction of stone formation. The clinical efficacy is mainly due to several additive or 
synergistic pharmacodynamic effects. Herbal drugs for therapy of urolithiasis were shown to be 
safe during long-termtherapy [1, 2]. Scientific monographs of the herbal urologicals are available 
from the ESCOP (European Scientific Cooperative on Phytotherapy; monographs from 2003 and 
2009). For some drugs and preparations the traditional use in urology has been acknowledged by 
the European Committee on Herbal Medicinal Products (hitherto inmonographs on Equiseti 
herba, Urticae herba and folium, and Solidaginis herba). 
Canephron® N is a fixed combination of centaury herb (Centaurium spec.), lovage root 
(Levisticum officinale Koch) and rosemary leaves (Rosmarinus officinalis L.). Overall, the drugs 
exert diuretic [3, 4] spasmolytic [6, 7], anti-inflammatory [7, 8, 9], antimicrobial [10, 11, 12, 13], 
and nephroprotective effects [14].  
In Moldova the combination is registered as diuretic for single or additive treatment of 
chronic infections of urinary tract, for non-infectious chronic inflammations of the kidneys and 
for urolithiasis. The combination had been introduced to the market in several countries more 
than 40 years ago. Some trials had shown its efficacy in the treatment of urinary tract diseases 
alongside with an excellent safety profile [1, 15, 16]. 
 
The aim of the study  
To determine the effectiveness of usage Canephron®N (dragees) in the complex 
prophylaxis of recurrent stone formation in patients with urolithiasis.  
  
Materials and methods 
An open, single-center prospective randomized controlled study was conducted on the 
Clinic of Urology and Operational Nephrology of the State University of Medicine and 
Pharmacy, Chisinau, the Republic of Moldova.  
A thorough clinical examination, including anamnestic data, previous treatment, 
identification of metabolic disorders, etc. were performed for all patients before inclusion in the 
study. 
The inclusion criteria were: 
– Men and women aged 18-70 years 
– Presence of stones in kidney and ureters, which were treated by open surgery, 
ureteroscopy, ESWL or medical expulsion therapy. 
The exclusion criteria were: 
– Idiosyncrasy to drug components 
– A pronounced accompanying pathology (Diabetes mellitus, coronary heart disease 
etc.) 
All patients, included in the study, underwent a standard metaphylaxis of UL, which 
included the treatment, aimed at: 
– liquidation of infectious-inflammatory process 
– improvement of microcirculation in the kidney tissue 
– fluid intake of no less than 2 liters per day in the absence of contraindications 
related with cardiovascular system  
– prescription, depend on the chemical composition of stone and discovered 
metabolic disorders, of: 
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• diet therapy limiting the intake of stone forming elements or its precursors in 
the body  
• medicamentous correction of hyperuricemia, hyperuricuria, hypercalciuria, 
hyperoxaluria, acid-base balance of urine 
In addition to the standard metaphylaxis (Control group), patients in Study group were 
given Canephron®N – 2 dragées three times a day, during 3-month course, each 6 months.  
Every 6 months, biochemical, microbiological, ultrasound and, if necessary, X-ray 
examinations were performed for patients, included in the study.  
The main criterion of therapy effectiveness was occurrence of recurrent stone formation 
in the both groups.  
Student's t test and Fisher's exact test were used to process the data. Statistical 
significance was considered achieved when p<0,05.  
 
Results 
A total of 86 patients with urolithiasis have been included in study (table 1). Patients 
distribution according to sex was 32 (37%) women and 54 (62%) men, average age 42±12 years 
old (from 20 to 62). All patients have undergone outpatient supervision 2-5 years.  
Table 1  
Baseline patient demographic and anamnestic characteristics 
 
 Group of study (n=50) Control group (n=36) 
Age, years old  45±11,2 (22 – 61) 42±9,2 (20 – 62) 
Gender, male/female (%) 31(62%)/19(38%) 23(64%)/13(36%) 
Duration of the supervision, 
years 
3,4±1,0 (2 – 5) 3,5±1,1 (2 – 5) 
Duration of the disease, years 8,6±4,1 (2 – 15) 8,1±4,0 (2 – 14) 
Recurrent stone formation in 
anamnesis 
48 (96%) 32 (89%) 
Urinary Tract Infection 31 (62%) 21 (58%) 
Composition of concrements:   
Urates 11 (22%) 9 (25%) 
Phosphates 12 (24%) 10 (28%) 
Oxalates 27 (54%) 17 (47%) 
Note: Data are expressed as absolute number (%) or Mean ± Standard Error (range);  
 
Stone composition in anamnesis: 
– in 44 (51%) patients - calcium oxalate,  
– in 22 (25,5%) – phosphate,  
– in 20 (23%) – uric acid. 
By the beginning of prophylactic treatment, after operative removal of concrements, the 
disease lasted for 2 – 15 years, 80 (93%) patients had recurrent stone formation, 58 (67%) 
patients were underwent open surgery or ureteroscopy, 20 (23%) - ESWL, in 8 (10%) patients 
the stones eliminated spontaneous. Infectious-inflammatory process in the urinary system was 
diagnosed in 52 (60%) patients. 
As it shown in Table 1, at the study beginning, statistically significant differences 
between treatment groups were not revealed. 
In the group Canephron®N recurrent concrements have been revealed in 8 (16%) 
patients, while in the control group in 13 (36%) patients (figure 1). Use of Canephron®N 






Statistical data show a significant decrease in frequency of recurrence in case of 
phosphate urolithiasis (figure 2).  
 

























Use of metaphylactic treatment of urolithiasis with Canephron®N allows reliably 
decrease the possibility of development of recurrent stone formation.  
The complex of pharmacological effects of phyto-medicine Canephron®N (anti-
inflammatory, antibacterial, antispasmodic, diuretic action) allows us characterizing it as a drug 
of choice for an effective, complex metaphylaxis of urolithiasis.  
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Fig. 2. Rate of stone recurrence according of 
chemical structure of the stones.  
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Summary 
The Importance of the Computed Tomography and Ultrasonography in  
Diagnosing Acute Pyelonephritis in Patients with Diabetes Mellitus 
The impairement of the renal function in diabetics represents a serious problem in therapy, 
endocrinology as well in urology. The inflammatory renal and urinary pathways diseases are 
known to be more frequent in diabetics than in non-diabetics, and they have a severe 
development, complicated by the renal failure and urosepsis, with a lethal ending. 
The development of severe forms of AP is determined by such factors as: the late 
hospitalization, the unclear clinical picture, the late diagnosis and the inadequate treatment of 
this category of patients. The association of these two severe diseases endangers the life of these 
patients. 
This survey has determined us to realize the retrospective evaluation of the obtained 
clinical data and to advance some practical recommendations. 
The algorithm of the emergency investigations includes the ultrasound scanning, 
radiologic and radionuclear procedures, but the top place is occupied by ultrasound scanning 
using the Doppler imaging and the computed tomography. 
At present among the most used and effective methods of diagnosing acute pyelonephritis 
in diabetics is computed tomography. 
 
Rezumat 
  Afectarea rinichiului în cazul DZ constituie o problemă serioasă atît în terapie şi 
endocrinologie, cît şi în urologie, se ştie că maladiile inflamatorii ale rinichiului şi ale căilor 
urinare la bolnavii cu DZ este mai freceventă, decît la persoanele fără diabet şi se caracterizează 
prin o evoluţie gravă, deseori complicată de insuficienţă renală şi urosepsis, complicată cu sfîrşit 
letal.  
Dezvoltarea formelor grave ale PA este, condiţionată de internarea tardivă, tabloul clinic 
neclar, diagnosticării tardive şi tratării neadecvate a acestui contingent de bolnavi. Combinaţia 
acestot două maladii grave, crează un pericol potenţial pentru viaţa acestor bolnavi. 
